MARX Biotech Co., Ltd. (TPEX:7731)

Taiwan · Delayed Price · Currency is TWD

4.420

-0.130 (-2.86%)

Aug 19, 2026, 10:19 AM CST

MARX Biotech Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	635.85	635.85	618.23	289.93	110.64	-
Revenue Growth	-10.80%	2.85%	113.24%	162.04%	-	-
Gross Profit	394.59	394.59	430.07	214.59	84.21	-
Operating Income	-142.15	-142.15	-85	-16.89	0.9	-0.83
Net Income	42.92	42.92	-96.83	-12.92	2.83	4.43
Earnings Per Share	0.08	0.08	-0.19	-0.04	0.01	0.14
EPS Growth	-	-	-	-	-94.05%	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Taiwan	632.33	632.33	615.54	284.62	104.45
China	0.97	0.97	1.03	3.3	4.39
Singapore and Malaysia	0.8	0.8	1.66	2	1.8
United State	1.75	1.75	-	-	-
Total	635.85	635.85	618.23	289.93	110.64

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	34.77	34.77	78.17	152.83	27.73	0.18
Total Debt	306.69	306.69	277.32	1.88	13.84	-
Net Cash (Debt)	-271.92	-271.92	-199.15	150.94	13.89	0.18
Net Cash Growth	-	-	-	986.39%	7705.62%	-
Net Cash Per Share	-0.52	-0.52	-0.40	0.47	0.04	0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-148.73	-148.73	-107.18	-17.13	11.44	0.31
Capital Expenditures	-9.34	-9.34	-206	-1.04	-0.7	-
Free Cash Flow	-158.06	-158.06	-313.18	-18.17	10.74	0.31
Free Cash Flow Growth	-	-	-	-	3343.27%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	62.06%	62.06%	69.56%	74.02%	76.11%	-
Operating Margin	-22.36%	-22.36%	-13.75%	-5.83%	0.81%	-
Pretax Margin	9.09%	9.09%	-15.76%	-5.34%	4.43%	-
Profit Margin	6.75%	6.75%	-15.66%	-4.46%	2.56%	-
FCF Margin	-24.86%	-24.86%	-50.66%	-6.27%	9.71%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	82.03	56.82	-	-	-	-
PS Ratio	4.06	3.84	5.69	-	-	-